EUVIMEDEUVIMED entdecken
Crossref

Biomineralized Bacterial Biohybrid for Coordinated and Self‐Sustained In Situ Synthesis of Antitumor Photothermal Agent and Photosensitizer

Kai Jin, Yue Zhang, Yi Huang, Lin Yu, Yuwei Zhong, Luqi Niu, Yihan Wu iD

Advanced Healthcare Materials · 2025

DOI: 10.1002/adhm.202504077 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Kai Jin und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Environmental and Chemical Engineering, Shanghai University, Shanghai, China. Hauptthemen laut MEDLINE: Photosensitizing Agents, Photothermal Therapy, Antineoplastic Agents. Die Arbeit nennt 64 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shenzhen Medical Research Fund, Fund for Innovative Research Team of High-Level Local Universities in Shanghai.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Synergizing photodynamic therapy (PDT) and photothermal therapy (PTT) in a single platform is a promising strategy against cancer, but its efficacy requires simultaneous delivery of sufficient amounts of both therapeutic agents for PDT and PTT. Here, we develop a CuS‐mineralized bacterial biohybrid, EcN‐HT@CuS, that synthesizes photosensitizer (protoporphyrin IX) and photothermal agent (melanin) continuously in situ within tumors, relying on no external substrate supply. The biohybrid, engineered with inducible genetic circuits encoding 5‐aminolevulinate synthase for synthesis of protoporphyrin IX precursor and tyrosinase for melanin production, is surface‐mineralized with CuS nanoparticles to supply the Cu 2+ cofactor for apo‐tyrosinase. EcN‐HT@CuS selectively colonizes and proliferates within tumors and is programmed to produce protoporphyrin IX and melanin on‐demand, allowing sequenced PDT and PTT mediated by red light and near‐infrared light, respectively. The combination therapy induced immunogenic tumor cell death, evidenced by robust infiltration of CD8 + T cells and a shift toward a proinflammatory tumor microenvironment. This work establishes a programmable antitumor biohybrid system that integrates targeted drug delivery, controlled phototherapy, and immune activation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Photosensitizing AgentsPhotothermal TherapyAntineoplastic AgentsAnimalsProtoporphyrinsMicePhotochemotherapyMelaninsCell Line, TumorCopperHumansNanoparticlesFemale

Stichwörter der Autor:innen

antitumor therapybiohybridlive therapeuticsphototherapysynthetic biology

Substanzen

Photosensitizing AgentsProtoporphyrinsprotoporphyrin IXMelaninsCopperAntineoplastic Agents

Autor:innen und Institutionen

  • School of Environmental and Chemical Engineering, Shanghai University, Shanghai, China.
  • School of Medicine, Shanghai University, Shanghai, China.
  • Zhejiang University School of Medicine, Hangzhou, China.

ORCID-Profile: Yihan Wu

Förderung

  • National Natural Science Foundation of China
  • Shenzhen Medical Research Fund
  • Fund for Innovative Research Team of High-Level Local Universities in Shanghai

Zitieren

APA

Jin, K., Zhang, Y., Huang, Y., Yu, L., Zhong, Y., Niu, L., & Wu, Y. (2025). Biomineralized Bacterial Biohybrid for Coordinated and Self‐Sustained In Situ Synthesis of Antitumor Photothermal Agent and Photosensitizer. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202504077

Vancouver

Jin K, Zhang Y, Huang Y, Yu L, Zhong Y, Niu L, et al. Biomineralized Bacterial Biohybrid for Coordinated and Self‐Sustained In Situ Synthesis of Antitumor Photothermal Agent and Photosensitizer. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202504077

BibTeX
@article{Jin2025,
  author = {Jin, Kai and Zhang, Yue and Huang, Yi and Yu, Lin and Zhong, Yuwei and Niu, Luqi and Wu, Yihan},
  title = {Biomineralized Bacterial Biohybrid for Coordinated and Self‐Sustained In Situ Synthesis of Antitumor Photothermal Agent and Photosensitizer},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  doi = {10.1002/adhm.202504077}
}
Kostenlos starten →